Enauta Participacoes SA (QGEP3):企業の財務・戦略的SWOT分析

◆英語タイトル:Enauta Participacoes SA (QGEP3) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDGE336789FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:Oil and Gas
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Enauta Participacoes SA (Enauta), a subsidiary of Queiroz Galvao Group, is an oil and gas company that explores, develops and produces oil and gas properties. The company’s exploration properties include Santos Basin, Espirito Santo Basin, Camamu-Almada Basin, Sergipe-Alagoas Basin, Pernambuco-Paraiba Basin, Ceara Basin, Para-Maranhao Basin, and Foz do Amazonas Basin. It also explores and produces hydrocarbon reserves. Enauta’s development assets comprise Atlanta and Oliva fields, and Camarao Norte Basin. It also carries out tests in order to verify the reserve estimates and to support the production curve. The company conducts production and discovery activities in Manati field. Enauta is headquartered in Rio de Janeiro, Brazil

Enauta Participacoes SA Key Recent Developments

Apr 08,2021: Enauta receives ANP approval and takes over 100% working interest in Atlanta Field
Feb 10,2021: Talos, Enauta consortium places bid for Petrobras Albacora fields, sources say
Jan 27,2021: Transition to a new command: Décio Oddone is the new CEO
Dec 21,2020: Brazil oil firm Enauta takes over Atlanta field, Barra Energia exits

This comprehensive SWOT profile of Enauta Participacoes SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Enauta Participacoes SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Enauta Participacoes SA – Key Information
Enauta Participacoes SA – Overview
Enauta Participacoes SA – Key Employees
Enauta Participacoes SA – Key Employee Biographies
Enauta Participacoes SA – Key Operational Heads
Enauta Participacoes SA – Major Products and Services
Enauta Participacoes SA – History
Enauta Participacoes SA – Company Statement
Enauta Participacoes SA – Locations And Subsidiaries

Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Enauta Participacoes SA – Business Description
Enauta Participacoes SA – Corporate Strategy
Enauta Participacoes SA – SWOT Analysis
SWOT Analysis – Overview
Enauta Participacoes SA – Strengths
Enauta Participacoes SA – Weaknesses
Enauta Participacoes SA – Opportunities
Enauta Participacoes SA – Threats
Enauta Participacoes SA – Key Competitors

Section 3 – Company Financial Performance Charts

Enauta Participacoes SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Enauta Participacoes SA, Key Information
Enauta Participacoes SA, Key Ratios
Enauta Participacoes SA, Share Data
Enauta Participacoes SA, Major Products and Services
Enauta Participacoes SA, History
Enauta Participacoes SA, Key Employees
Enauta Participacoes SA, Key Employee Biographies
Enauta Participacoes SA, Key Operational Heads
Enauta Participacoes SA, Other Locations
Enauta Participacoes SA, Subsidiaries

Enauta Participacoes SA, Key Competitors
Enauta Participacoes SA, SWOT Analysis
Enauta Participacoes SA, Ratios based on current share price
Enauta Participacoes SA, Annual Ratios
Enauta Participacoes SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Enauta Participacoes SA (QGEP3):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • 3-D Matrix Ltd (7777):医療機器:M&Aディール及び事業提携情報
    Summary 3-D Matrix Ltd (3-D Matrix) is a regenerative medicine company that focuses at commercializing its self-assembling peptide technology. It develops medical products by applying this technology under a license granted by Massachusetts Institute of Technology (MIT). The technology finds applica …
  • PledPharma AB (PLED):企業の財務・戦略的SWOT分析
    Summary PledPharma AB (PledPharma) is a pharmaceutical company that discovers, manufactures, and develops drugs that protect the body against oxidative stress. The company discovers and develops Aladote and PledOx drugs. PledOX drug is used to prevent chemotherapy-induced side effects for colorectal …
  • Stobart Group Limited (STOB):企業の財務・戦略的SWOT分析
    Stobart Group Limited (STOB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Charles River Laboratories International Inc (CRL):製薬・医療:M&Aディール及び事業提携情報
    Summary Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. Th …
  • HomeWorks Tri-County Electric Cooperative Inc:企業の戦略的SWOT分析
    HomeWorks Tri-County Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Immucor, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary Immucor, Inc. (Immucor) is an in-vitro diagnostics company, which specializes in the area of pre-transfusion diagnostics. It carries out the development, production and sale of a comprehensive line of reagents and automated systems. The company’s products are used in performing the tests to …
  • CivaTech Oncology Inc:医療機器:M&Aディール及び事業提携情報
    Summary CivaTech Oncology Inc (CivaTech) is a medical device company that provides radiation therapy solutions. The company develops polymer based low dose rate (LDR) brachytherapy devices for the treatment of cancer. Its product portfolio includes CivaString, a radiation therapy device to treat sol …
  • Medtronic PLC:企業の戦略・SWOT・財務情報
    Medtronic PLC - Strategy, SWOT and Corporate Finance Report Summary Medtronic PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Itochu Corp (8001):石油・ガス:M&Aディール及び事業提携情報
    Summary Itochu Corp (Itochu) is a trading company. It offers domestic trading, import and export, and overseas trading. The company trades in products such as textile, machinery, metals, minerals, energy, chemicals, food, general products, information and communications technology, realty, insurance …
  • Sermonix Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Sermonix Pharmaceuticals LLC (Sermonix) is a biotechnology company develops female-specific oncology products. The company provides lead product such as lasofoxifene, which is a selective estrogen receptor modulator. Its lasofoxifene is used in the treatment of common disorders affecting wom …
  • Ultragenyx Pharmaceutical Inc (RARE):製薬・医療:M&Aディール及び事業提携情報
    Summary Ultragenyx Pharmaceutical Inc (Ultragenyx) is a biotechnology company that develops life-enhancing therapeutics for rare and ultra-rare genetic diseases. Its only marketed product, Mepsevii (vestronidase alfa) is the first indication approved for the treatment of adults and children with Muc …
  • Strategic Resources Inc. (STI):企業の財務・戦略的SWOT分析
    Strategic Resources Inc. (STI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Korea Research Institute of Bioscience and Biotechnology:製薬・医療:M&Aディール及び事業提携情報
    Summary Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute which provides bioinformatic services. The institute operates in the fields of strategic research, biomedical sciences, system biology and bioengineering, business development, and bioinfrastr …
  • SkinMedica Inc-製薬・医療分野:企業M&A・提携分析
    Summary SkinMedica Inc (SkinMedica) is a manufacturer and distributor of skin care products. The company’s products include purifying foaming wash, facial cleanser, skin polisher, purifying toner, TNS recovery complex, uplifting eye serum, restorative ointment, dermal repair cream, and post procedur …
  • Erin Energy Corp (ERN):企業の財務・戦略的SWOT分析
    Summary Erin Energy Corp (Erin Energy), formerly CAMAC Energy Inc, a subsidiary of CAMAC Energy Holdings Ltd, is an oil and gas company that develops and produces oil and gas assets. The company's portfolio includes seven licenses in four countries and covers an area of approximately 19,000 sq km of …
  • Arkle Resources Plc
    Arkle Resources Plc - Strategy, SWOT and Corporate Finance Report Summary Arkle Resources Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Dunavant Enterprises, Inc.:企業の戦略・SWOT・財務分析
    Dunavant Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dunavant Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Shockwave Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Shockwave Medical Inc (Shockwave) is a medical device provider for the treatment of advanced cardiovascular diseases. The company specializes in reshaping cardiovascular interventional therapy with intravascular lithotripsy (IVL) technology which built on balloon catheter platform for the tr …
  • Tosoh Bioscience Inc:企業の製品パイプライン分析2018
    Summary Tosoh Bioscience Inc (TBI), a subsidiary of Tosoh Corp, is a medical device company that offers diagnostic systems. The company provides analyzers, assays, immunoassay solutions, reagent technology, HbA1c solutions, ß-thalassemia testing, and HPLC technology. Its immunoassay solutions compri …
  • Deutsche Ruckversicherung AG:企業の戦略・SWOT・財務情報
    Deutsche Ruckversicherung AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Ruckversicherung AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆